NCT04593043View on ClinicalTrials.gov

Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

78,140

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Atrial Fibrillation
Interventions
DRUG

Warfarin

Warfarin dispensing claim is used as the reference

DRUG

Dabigatran

Dabigatran dispensing claim is used as the exposure

Trial Locations (1)

02120

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04593043 - Replication of the RELY Anticoagulant Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter